Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Goodwill & Intangibles (2019 - 2026)

Revolution Medicines has reported Goodwill & Intangibles over the past 7 years, most recently at $14.6 million for Q4 2025.

  • For Q4 2025, Goodwill & Intangibles fell 81.24% year-over-year to $14.6 million; the TTM value through Dec 2025 reached $14.6 million, down 81.24%, while the annual FY2025 figure was $14.6 million, 81.24% down from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $14.6 million at Revolution Medicines, down from $70.4 million in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $77.9 million in Q2 2021 and troughed at $14.6 million in Q4 2025.
  • A 5-year average of $70.4 million and a median of $72.1 million in 2023 define the central range for Goodwill & Intangibles.
  • Biggest five-year swings in Goodwill & Intangibles: grew 10.62% in 2021 and later crashed 81.24% in 2025.
  • Year by year, Goodwill & Intangibles stood at $70.4 million in 2021, then changed by 0.0% to $70.4 million in 2022, then rose by 2.75% to $72.3 million in 2023, then increased by 7.66% to $77.9 million in 2024, then crashed by 81.24% to $14.6 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for RVMD at $14.6 million in Q4 2025, $70.4 million in Q3 2025, and $77.9 million in Q2 2025.